Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Metsera
Developing next-gen obesity therapies
Biotech
Biotech's top money raisers: 2024
With an eye-popping $1 billion raised last April, no other biotech managed to come close to Xaira’s massive haul.
Gabrielle Masson
Mar 3, 2025 5:00am
Metsera, Maze go public with IPOs of $275M, $113M
Jan 31, 2025 7:40am
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Jan 27, 2025 11:00am
Obesity biotech Metsera files for a swift IPO
Jan 11, 2025 9:05am
Metsera links GLP-1 drug to 11% weight loss after 12 weeks
Jan 7, 2025 8:32am
Metsera follows phase 1 weight loss data with $215M series B
Nov 13, 2024 9:15am
